Buspirone
7,545 views
Psych Pharm
- Lithium
- Typical Antipsychotics
- Atypical Antipsychotics
- SSRIs
- SNRIs
- Tricyclic Antidepressants (TCAs)
- Monoamine Oxidase Inhibitors (MAOIs)
- Bupropion
- Mirtazapine
- Trazadone
- Vilazodone
- Vortioxetine
- Buspirone
- Varenicline
Summary
Buspirone is a medication that acts as a partial agonist at serotonin receptors. This drug is a second-line treatment for General Anxiety Disorder. Remember that buspirone has a slow onset of action, roughly taking 2 weeks before clinical symptoms improve. 
Key Points
- Buspirone- Mechanism- Acts as partial agonist of serotonin 5-HTA1 receptors
- Acts as weak antagonist at dopamine D2 receptors
 
- Indications- Treats Generalized Anxiety Disorder (GAD)- Acts as nonbenzodiazepine anxiolytic
- Has a slow onset of action of 2 weeks - Not effective in treating acute anxiety attacks
 
- Used as 2nd line pharmacologic treatment for GAD after SSRIs/SNRIs.
 
 
- Treats Generalized Anxiety Disorder (GAD)
- Side Effects- No risk of tolerance, dependence, or withdrawal - Contrast vs. benzodiazepines
 
- Less sedative and hypnotic effects - Contact vs. benzodiazepines
 
- Minimal side effects (dizziness)
 
- No risk of tolerance, dependence, or withdrawal 
 
- Mechanism